FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973259574> ?p ?o ?g. }

• W1973259574 abstract "Background: The androgen receptor (AR) and PI3K/AKT/mTOR signaling axis are two key pathways that are activated in prostate cancer (PC). Although interference with the AR axis is the common first-line treatment for controlling metastatic recurrent PC, fast-growing PC progresses rapidly on hormone therapy and chemotherapy to a terminal condition within 18 to 24 months. Inhibitors of the PI3K/AKT/mTOR axis, such as rapamycin and the dual inhibitor BEZ-235 (Novartis), are ineffective in treating metastatic PC in part due to feedback regulations that activate the AR axis. Reciprocally, inhibition of AR activity reduces the expression of an AKT phosphatase, which is an AR target gene, with consequent increase of the AKT kinase activity. The antibiotic salinomycin, a product of the bacterium Streptomyces albus, has known anti-neoplastic activity, and in a screen of 16,000 small molecules, salinomycin was found to be the most potent in causing apoptosis of breast cancer stem cells. We previously reported that salinomycin treatment elevated intracellular oxidative stress and induced growth arrest of PC cells due to apoptosis. Design and Results: Here we report further elaboration of the underlying mechanism for growth arrest of androgen-dependent (LNCaP) and castration-resistant (C4-2B) human prostate cancer cells by salinomycin at sub-micromolar concentrations. We report that salinomycin can significantly reduce mTOR activity in both LNCaP and C4-2B cells without altering the mTOR activity of non-malignant RWPE-1 prostate epithelial cells. The specificity of the salinomycin effect is evidenced by the result that other anti-cancer agents such as docetaxel, the plant lignan deoxypodophyllotoxin and vitamin D did not alter mTOR activity. Preliminary results suggest that salinomycin may also induce autophagy in PC cells. Importantly, AR expression was markedly reduced in salinomycin-treated prostate cancer cells, suggesting dual targeting of the AR pathway and PI3K/AKT/mTOR axis by this antibiotic. Conclusion: We conclude that salinomycin targets two pivotal pathways that promote prostate cancer progression. Unlike other PI3K/AKT/mTOR inhibitors, the AR-activating feedback cross regulation did not compromise the therapeutic potential of salinomycin. Salinomycin-targeted interventions of the survival signals for castration-resistant PC will further avoid chemotherapy-induced toxicity. Preclinical validation of our results will pave the way for testing the efficacy of salinomycin against prostate cancer in a clinical setting. Supported by a Merit-Review grant from the Department of Veterans Affairs. Citation Format: Nooshin Mirkheshti, Chung Song, Bandana Chatterjee. The antibiotic salinomycin cotargets two pivotal pathways in prostate cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3312. doi:10.1158/1538-7445.AM2014-3312" @default.
• W1973259574 created "2016-06-24" @default.
• W1973259574 creator A5013241382 @default.
• W1973259574 creator A5025790857 @default.
• W1973259574 creator A5028122104 @default.
• W1973259574 date "2014-09-30" @default.
• W1973259574 modified "2023-09-25" @default.
• W1973259574 title "Abstract 3312: The antibiotic salinomycin cotargets two pivotal pathways in prostate cancer" @default.
• W1973259574 doi "https://doi.org/10.1158/1538-7445.am2014-3312" @default.
• W1973259574 hasPublicationYear "2014" @default.
• W1973259574 type Work @default.
• W1973259574 sameAs 1973259574 @default.
• W1973259574 citedByCount "0" @default.
• W1973259574 crossrefType "proceedings-article" @default.
• W1973259574 hasAuthorship W1973259574A5013241382 @default.
• W1973259574 hasAuthorship W1973259574A5025790857 @default.
• W1973259574 hasAuthorship W1973259574A5028122104 @default.
• W1973259574 hasConcept C121608353 @default.
• W1973259574 hasConcept C126322002 @default.
• W1973259574 hasConcept C190283241 @default.
• W1973259574 hasConcept C2777877089 @default.
• W1973259574 hasConcept C2779723316 @default.
• W1973259574 hasConcept C2780192828 @default.
• W1973259574 hasConcept C501593827 @default.
• W1973259574 hasConcept C502942594 @default.
• W1973259574 hasConcept C55427017 @default.
• W1973259574 hasConcept C55493867 @default.
• W1973259574 hasConcept C71924100 @default.
• W1973259574 hasConcept C75217442 @default.
• W1973259574 hasConcept C86554907 @default.
• W1973259574 hasConcept C86803240 @default.
• W1973259574 hasConceptScore W1973259574C121608353 @default.
• W1973259574 hasConceptScore W1973259574C126322002 @default.
• W1973259574 hasConceptScore W1973259574C190283241 @default.
• W1973259574 hasConceptScore W1973259574C2777877089 @default.
• W1973259574 hasConceptScore W1973259574C2779723316 @default.
• W1973259574 hasConceptScore W1973259574C2780192828 @default.
• W1973259574 hasConceptScore W1973259574C501593827 @default.
• W1973259574 hasConceptScore W1973259574C502942594 @default.
• W1973259574 hasConceptScore W1973259574C55427017 @default.
• W1973259574 hasConceptScore W1973259574C55493867 @default.
• W1973259574 hasConceptScore W1973259574C71924100 @default.
• W1973259574 hasConceptScore W1973259574C75217442 @default.
• W1973259574 hasConceptScore W1973259574C86554907 @default.
• W1973259574 hasConceptScore W1973259574C86803240 @default.
• W1973259574 hasLocation W19732595741 @default.
• W1973259574 hasOpenAccess W1973259574 @default.
• W1973259574 hasPrimaryLocation W19732595741 @default.
• W1973259574 hasRelatedWork W1970285863 @default.
• W1973259574 hasRelatedWork W2030402361 @default.
• W1973259574 hasRelatedWork W2035246749 @default.
• W1973259574 hasRelatedWork W2052468128 @default.
• W1973259574 hasRelatedWork W2064425366 @default.
• W1973259574 hasRelatedWork W2068347341 @default.
• W1973259574 hasRelatedWork W2077807612 @default.
• W1973259574 hasRelatedWork W2087275028 @default.
• W1973259574 hasRelatedWork W2107204247 @default.
• W1973259574 hasRelatedWork W2114645683 @default.
• W1973259574 hasRelatedWork W2127782142 @default.
• W1973259574 hasRelatedWork W2166435610 @default.
• W1973259574 hasRelatedWork W2324285809 @default.
• W1973259574 hasRelatedWork W2474618176 @default.
• W1973259574 hasRelatedWork W2532154357 @default.
• W1973259574 hasRelatedWork W2590128314 @default.
• W1973259574 hasRelatedWork W2916401593 @default.
• W1973259574 hasRelatedWork W3092074436 @default.
• W1973259574 hasRelatedWork W2498839141 @default.
• W1973259574 hasRelatedWork W3143882310 @default.
• W1973259574 isParatext "false" @default.
• W1973259574 isRetracted "false" @default.
• W1973259574 magId "1973259574" @default.
• W1973259574 workType "article" @default.